anonymous
Guest
anonymous
Guest
Are you offer yourself up then? Doesn’t matter what shitshow is in place…AZ did it that way for whatever reason. None of the non-Onc/rare TAs make sense with the current structure. Whatever cuts are coming, they are going to be big. AZ is losing the #1 earner of all time with Farxiga and the money sucking sham of Brilinta this year. They have Lokelma and Bax coming out that can be covered by PCP and a contract force.On the CVRM side? Or, R&I, as well? It's a shit show out there...entirely too many reps. More is NOT more. A reduction is beyond necessary.
All investments are going into Onc. All of the rest of us are on the chopping block. Period.